Concepedia

Publication | Open Access

Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies

DOIFull Paper Access

362

Citations

32

References

2016

Year

Alain P. Algazi, Katy K. Tsai, Alexander N. Shoushtari, Rodrigo Ramella Munhoz, Zeynep Eroglu, Josep M. Piulats, Patrick A. Ott, Douglas B. Johnson, Jimmy J. Hwang, Adil Daud,
Cancer

Abstract

PD-1 and PD-L1 antibodies rarely confer durable remissions in patients with metastatic uveal melanoma. Clinical trial enrollment should be prioritized in this population. Cancer 2016;122:3344-3353. © 2016 American Cancer Society.

References

YearCitations

Page 1